Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Study of Novel Treatment Combinations in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden
- Status
- COMPLETED
- Phase
- N/A
Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of Relatlimab in Combination With Nivolumab in Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2